Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and signaling fullness to your brain, which clinical trials show leads to an average weight loss of 15% of body weight over 68 weeks. However, monthly weight loss varies significantly from person to person. Understanding realistic timelines and individual factors helps you set appropriate expectations for your treatment journey.
Average Monthly Weight Loss Results on Semaglutide
Most people using semaglutide lose between 4–8 pounds per month during the first three months of therapy. This initial phase often feels most dramatic because your appetite decreases significantly and your relationship with food shifts. The pace typically slows after month three as your body adapts to the medication and you reach a new baseline of food intake.
Long-term data shows that patients maintain steady weight loss of 2–3 pounds per month once they reach their optimal dose. Individual results depend heavily on your starting weight, metabolic health, adherence to consistent dosing, and whether you combine the medication with dietary and exercise modifications. Someone beginning treatment at 250 pounds will likely see faster initial losses than someone starting at 180 pounds, simply due to the mathematics of percentage-based weight loss.
Timeline: What to Expect in Your First Six Months
Week 1–2: Most patients notice reduced appetite within the first few days, though actual weight loss may be minimal. This early phase confirms the medication is working at a neurological level. You might experience mild nausea or digestive changes as your body adjusts.
Month 1–2: Average weight loss of 5–10 pounds occurs during this window as the appetite-suppressing effects compound. Dosing typically starts low and gradually increases, so your results may accelerate as your dose reaches therapeutic levels. This is when many people begin noticing clothes fitting differently.
Month 3–6: Monthly losses stabilize around 3–6 pounds per month as you reach your optimal dose. Your eating patterns have usually normalized at a lower calorie intake without requiring constant willpower. By month six, total weight loss typically ranges from 15–30 pounds, depending on starting point and adherence.
Factors That Influence Your Individual Weight Loss Rate
Your genetic makeup plays a crucial role in how your body responds to semaglutide. Variants in the GLP1R gene affect how well your GLP-1 receptors function, while FTO and MC4R variants influence appetite regulation and metabolic efficiency. PlexusDx's Precision Peptide Genetic Test identifies these 14 key pathways involving 49 peptides, helping predict which patients will respond optimally to semaglutide versus combination therapy like tirzepatide.
Starting weight, baseline metabolism, sleep quality, stress levels, and physical activity all significantly impact monthly results. Someone with poor sleep and high stress may lose weight 20% slower than an otherwise identical person prioritizing rest and managing cortisol. Consistent strength training preserves muscle during weight loss and can actually accelerate fat loss, whereas sedentary weight loss leads to more muscle loss alongside fat loss.
Diet quality matters more than calorie counting on semaglutide. Because the medication dramatically reduces hunger, most people naturally eat less without tracking. However, someone eating primarily processed foods may lose weight slower than someone consuming protein-rich whole foods, due to thermic effects and nutritional density affecting metabolism and satiety.
Personalizing Your Semaglutide Therapy with PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A pharmacies, with no insurance required and HSA/FSA eligibility. Your dose may increase over time to achieve optimal results, but your monthly price remains flat—never tied to dose level. This pricing structure removes barriers to reaching your therapeutic dose without worrying about escalating costs.
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes how your unique genetic variants in GIPR, GLP1R, FTO, and MC4R influence your response to semaglutide and alternative peptide therapies. Patients with certain GLP1R variants may achieve faster weight loss on semaglutide alone, while others benefit from switching to tirzepatide or GLP-Squared (our dual-compound injection) for enhanced results. Testing removes guesswork and helps PlexusDx clinicians optimize your treatment from month two onward.
Realistic Expectations: Plateaus and Adjustments
Weight loss plateaus are normal and expected, typically occurring around months four to six as your body reaches a new equilibrium. A plateau lasting 2–3 weeks does not indicate medication failure; your dose may simply need adjustment, or lifestyle factors like increased stress or reduced sleep may be temporarily slowing progress. Discussing plateaus with your PlexusDx clinician allows for proactive dose optimization or strategic lifestyle modifications.
Some patients reach their target weight and choose to stay on semaglutide long-term as a maintenance medication, while others discontinue after significant loss and transition to behavioral strategies. Weight regain after stopping is common, as appetite returns to baseline; however, many patients retain 50–70% of their weight loss through sustained habit change and continued exercise. PlexusDx supports both approaches with month-to-month flexibility and no membership fees or long-term contracts.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight should I expect to lose in my first month on semaglutide?
Most people lose 4–8 pounds in their first month, though some lose less if they start at a very low dose. Weight loss accelerates as your dose increases toward therapeutic levels over weeks 2–4. Factors like starting weight, diet quality, and activity level cause individual variation.
Is the weight loss from semaglutide permanent?
Clinical trials show that approximately 50–70% of weight loss is retained long-term, even after discontinuing the medication. Weight regain happens primarily in patients who return to their original eating patterns; those who maintain behavioral changes typically keep most of their loss. PlexusDx supports ongoing therapy for patients who benefit from continued appetite suppression.
Can PlexusDx help me if I'm not losing weight as fast as expected?
Yes. PlexusDx offers the Precision Peptide Genetic Test to identify whether semaglutide is truly optimal for your genetic profile, or whether tirzepatide or GLP-Squared might accelerate results. Your clinician can also adjust dose, assess lifestyle factors, and recommend adjunctive strategies—all while maintaining your flat $149/month price for semaglutide.
What side effects might slow my weight loss progress?
Nausea, constipation, and reduced appetite are expected; they typically resolve within 1–2 weeks. Severe or persistent side effects should be reported to your PlexusDx clinician immediately, as dose adjustment or switching medications may be necessary. Most patients find side effects manageable and temporary compared to the appetite-suppressing benefits.
How does the Precision Peptide Genetic Test help predict my weight loss?
The test identifies your variants in GLP1R, GIPR, FTO, and MC4R genes—all linked to medication response and metabolism. Certain variants predict faster semaglutide response, while others suggest better results with tirzepatide. Testing at $99 after your first month allows PlexusDx clinicians to personalize your therapy and potentially double-down on what works best for your unique peptide pathways.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Long Does It Take to Compound Semaglutide? A Comprehensive Guide
Does Compound Semaglutide Need to Be Refrigerated? Essential Storage Guidelines